Preclinical development of a novel bispecific mAb-Trap fusion protein, IMM2902, targeting both HER2 and CD47 as cancer immunotherapyBinglei Zhang,Song Li,Dianze Chen,Dandan Liu,Huiqin Guo,Chunmei Yang,Li Zhang,Wei Zhang,Xiaoping Tu,Liang Peng,Gui Zhao,Ruliang Zhang, Frank X. Gan,Wenzhi Tian,Fan Zhang,Yongping SongCANCER RESEARCH(2023)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要